Fact CheckerSign in

NCT06944847Recruiting

Vaping and Smoking Project in People With Schizophrenia

A Laboratory Study of Behavior and Performance Among People Who Vape Nicotine and/or Smoke Cigarettes - Schizophrenia Supplement

Source: ClinicalTrials.gov · Last updated 9 Mar 2026

Brief summary (registry, in English)

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
64 (estimated)
First submitted
6 Apr 2025
Start date
15 Feb 2025
Primary completion date
1 Apr 2027
Lead sponsor
State University of New York at Buffalo
NCT number
NCT06944847

What you commit to

  • Study type: Interventional
  • Planned participants: 64
  • From 15 Feb 2025 to the primary completion date, 1 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • 6+ months of daily/near-daily nicotine vaping or cigarette smoking
  • 200+ ng/mL cotinine on a commercially-available quick screen
  • stable antipsychotic medication dose (no changes in past 6 months).
    • Current Exclusion Criteria:
  • intention to quit daily/near-daily vaping/smoking in the next month
  • current (2+ days out of the past 7) use of pipe tobacco, hookah/shisha, smokeless tobacco, dissolvable tobacco, nicotine pouches. For vaping group only, current (2+ days out of past 7) use of cigars, cigarillos, or filtered cigars that are filled with tobacco or a mix of tobacco and marijuana
  • current use of any smoking cessation medication
  • current severe substance dependence other than tobacco/nicotine (including cannabis; NIDA Modified ASSIST of 27+)
  • current (past 2 weeks) suicidal ideation with intent and/or plan
  • pregnancy (intake urine screen)
  • florid psychosis or severe cognitive symptoms (score of ≥5 on PANSS items delusions (P1), hallucinatory behavior (P3), or unusual thought content (G9), conceptual disorganization (P2), abstract thinking (N5), or poor attention (G11) or a score ≥6 on grandiosity (P5) or suspiciousness (P6)

Age in the registry: 21 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University at Buffalo
Coordinator of this site? Confirm its status
BuffaloUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.